MOR Wealth Management LLC Acquires New Holdings in Astera Labs, Inc. $ALAB

MOR Wealth Management LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,618 shares of the company’s stock, valued at approximately $782,000.

Other large investors have also recently added to or reduced their stakes in the company. Eurizon Capital SGR S.p.A. bought a new stake in Astera Labs during the fourth quarter valued at about $18,708,000. Swedbank AB increased its stake in shares of Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after purchasing an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new position in shares of Astera Labs in the fourth quarter worth about $499,000. Revere Asset Management Inc acquired a new position in shares of Astera Labs during the 4th quarter worth about $589,000. Finally, Banque Cantonale Vaudoise boosted its stake in Astera Labs by 85.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after purchasing an additional 3,229 shares during the period. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB stock opened at $310.40 on Friday. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The stock has a market cap of $53.85 billion, a price-to-earnings ratio of 153.66 and a beta of 3.77. The firm has a fifty day moving average of $330.74 and a 200-day moving average of $254.36.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period last year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for strong third-quarter growth and strengthening the company’s position in AI data-center infrastructure. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.80 versus the $0.69 consensus estimate and revenue of $392.4 million versus $360.85 million. Revenue rose 104.5% year over year, while management issued third-quarter EPS guidance of $1.16 to $1.21.
• Positive Sentiment: Analyst sentiment remains generally constructive: Astera Labs has a “Moderate Buy” consensus rating and an average price target of $348.33, above recent trading levels. Northland upgraded the shares to outperform with a $350 target, while Morgan Stanley maintained an overweight rating with a $335 target.
• Neutral Sentiment: Despite the favorable growth outlook, ALAB has declined 13.9% since its latest earnings report and 24% over the past month, reflecting elevated valuation expectations and uncertainty about the pace of future growth. The stock’s high beta and elevated earnings multiple may contribute to volatility. Why Is Astera Labs Down Since Its Earnings Report?
• Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his holdings by 41.9%. Director Stefan Dyckerhoff separately sold 12,499 shares worth about $3.4 million. The transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their value as a discretionary bearish signal, but the sales may still weigh on investor sentiment and add near-term supply. SEC Insider Trading Filing

Insider Activity

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $2,804,599.02. Following the sale, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. This represents a 69.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the transaction, the general counsel directly owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 592,244 shares of company stock valued at $209,729,973. 10.40% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ALAB. Barclays raised their target price on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Citigroup reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Roth Capital reaffirmed a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Finally, Stifel Nicolaus increased their price target on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus price target of $348.33.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.